1,8-cineole protects against liver failure in an in-vivo murine model of endotoxemic shock

Citation
Fa. Santos et al., 1,8-cineole protects against liver failure in an in-vivo murine model of endotoxemic shock, J PHARM PHA, 53(4), 2001, pp. 505-511
Citations number
37
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACY AND PHARMACOLOGY
ISSN journal
00223573 → ACNP
Volume
53
Issue
4
Year of publication
2001
Pages
505 - 511
Database
ISI
SICI code
0022-3573(200104)53:4<505:1PALFI>2.0.ZU;2-B
Abstract
The effects of 1,8-cineole on D-galactosamine/lipopolysaccharide (GalN/LPS) -induced shock model of liver injury was investigated in mice, The co-admin istration of GalN (700 mg kg(-1), i.p.) and LPS (5 mug kg(-1), i.p.) greatl y elevated serum concentrations of tumour necrosis factor-alpha (TNF-alpha) , alanine aminotransferase and aspartate aminotransferase, and induced mass ive hepatic necrosis and lethality in 100% of control mice. Pretreatment wi th 1,8-cineole (400 mo kg(-1), p.o.) and dexamethasone (l mg kg(-1), s.c.), 60 min before GalN/LPS, offered complete protection (100 %) against the le thal shock and acute elevation in serum TNF-alpha and serum transaminases. Hepatic necrosis induced by GalN/LPS was also greatly reduced by both 1,8-c ineole and dexamethasone treatment. The results indicate that 1,8-cineole p rotects mice against GalN/LPS- induced liver injury through the inhibition of TNF-alpha production, and suggest that 1,8-cineole may be a promising ag ent to combat septic-shock-associated pathologies.